A WORKSHOP on the use of innovative modelling and simulation approaches during the development and regulatory assessment of medicines will take place at the European Medicines Agency (EMA) on 21 Nov 2016.
The event is part of a public consultation on a new EMA guideline that was launched in Jul.
Visit www.ema.europa.eu.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Nov 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Nov 16